NorthView Acquisition (NVACR) Competitors $0.05 +0.01 (+44.24%) As of 01/21/2025 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NVACR vs. DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, CTCXW, CRGT, GMVDW, HSCSW, and BEATWShould you be buying NorthView Acquisition stock or one of its competitors? The main competitors of NorthView Acquisition include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Carmell (CTCXW), Cortigent (CRGT), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). These companies are all part of the "medical equipment" industry. NorthView Acquisition vs. Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Carmell Cortigent G Medical Innovations Heart Test Laboratories HeartBeam NorthView Acquisition (NASDAQ:NVACR) and Alpha Tau Medical (NASDAQ:DRTSW) are both manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk, community ranking and analyst recommendations. Does the media prefer NVACR or DRTSW? In the previous week, Alpha Tau Medical had 1 more articles in the media than NorthView Acquisition. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for NorthView Acquisition. Alpha Tau Medical's average media sentiment score of 0.40 beat NorthView Acquisition's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment NorthView Acquisition Neutral Alpha Tau Medical Neutral Which has stronger earnings & valuation, NVACR or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorthView AcquisitionN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Does the MarketBeat Community believe in NVACR or DRTSW? NorthView Acquisition and Alpha Tau Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNorthView AcquisitionN/AN/AAlpha Tau MedicalN/AN/A Is NVACR or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NorthView AcquisitionN/A N/A N/A Alpha Tau Medical N/A N/A N/A SummaryAlpha Tau Medical beats NorthView Acquisition on 2 of the 2 factors compared between the two stocks. Get NorthView Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for NVACR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVACR vs. The Competition Export to ExcelMetricNorthView AcquisitionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$15.47M$2.24B$9.13BDividend YieldN/AN/A2.62%4.00%P/E RatioN/AN/A27.5617.53Price / SalesN/A0.00139.13134.21Price / CashN/AN/AN/A32.90Price / BookN/AN/A2.024.69Net IncomeN/AN/A$165.18M$224.57M7 Day PerformanceN/A-2.79%1.44%1.69%1 Month PerformanceN/A137.58%2.64%5.34%1 Year PerformanceN/A91.00%8.21%21.47% NorthView Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVACRNorthView AcquisitionN/A$0.05+44.2%N/AN/A$0.00N/A0.002Gap UpHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.35+16.7%N/A+17.2%$0.00N/A0.0080Positive NewsANZUWAnzu Special Acquisition Corp IN/A$0.06+17.0%N/AN/A$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.04-19.8%N/AN/A$0.00N/A0.00N/AGap UpHigh Trading VolumeBBLGWBone BiologicsN/A$59.20+8.6%N/A+993.1%$0.00N/A0.002Positive NewsGap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011News CoverageCTCXWCarmellN/A$0.04-13.6%N/AN/A$0.00$32,839.000.0014Positive NewsGap UpCRGTCortigentN/AN/AN/AN/A$0.00N/A0.006High Trading VolumeGMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.05+8.0%N/AN/A$0.00$14,700.000.0010Positive NewsGap DownBEATWHeartBeamN/A$0.650.0%N/A+55.8%$0.00N/A0.005Positive NewsGap Up Related Companies and Tools Related Companies DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives BRSHW Alternatives CTCXW Alternatives CRGT Alternatives GMVDW Alternatives HSCSW Alternatives BEATW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NVACR) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NorthView Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NorthView Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVACR Stock Alerts